2008
DOI: 10.1177/1076029607309173
|View full text |Cite
|
Sign up to set email alerts
|

Fatal Bleeding Due to a Heparin-Like Anticoagulant in a 37-Year-Old Woman Suffering From Systemic Mastocytosis

Abstract: A 37-year-old female patient with systemic mastocytosis who was admitted with severe unexplained bleeding symptoms is studied. Laboratory procedures established the diagnosis of a patient-derived-heparin-like anticoagulant as a very rare hemostatic abnormality predisposing to bleeding. The patient died from refractory disease despite therapy with protamine, initiation of chemotherapy, and supportive measures. The case illustrates the clinical presentation and diagnosis of heparin-like anticoagulants. Etiology,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
32
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(33 citation statements)
references
References 23 publications
1
32
0
Order By: Relevance
“…Abrupt hypotension due to iodinated contrast in a patient with urticaria pigmentosa has also been described in the literature [19]. Excessive bleeding associated with mastocytosis may be due to heparin release by mast cells [20]- [23].…”
Section: Discussionmentioning
confidence: 91%
“…Abrupt hypotension due to iodinated contrast in a patient with urticaria pigmentosa has also been described in the literature [19]. Excessive bleeding associated with mastocytosis may be due to heparin release by mast cells [20]- [23].…”
Section: Discussionmentioning
confidence: 91%
“…Heparin-like anticoagulants have been described in a number of other diseases, including transitional cell carcinomas [6,7], breast cancer [8], multiple myeloma [9], systemic mastocytosis [10] and hepatocellular carcinoma [11].…”
Section: Discussionmentioning
confidence: 99%
“…Due to its uncommon occurrence, the treatment of HLArelated bleeding disorders is far from clear; the administration of protamine is anecdotal [9], and its efficacy equivocal [7,10,11].…”
Section: Discussionmentioning
confidence: 99%
“…32,47,48 There have been multiple case reports of excessive bleeding in patients with SM. [49][50][51] The propensity to bleed is unlikely related to thrombocytopenia (which is usually mild), but instead may be related to heparin-like anticoagulants caused by MC degranulation, along with the disruption of fibrinogen function by trypase. 51,52 Importantly, the increase in MC burden does not affect B-cell and T-cell number or function and, therefore, patients with SM are not immunocompromised, except in cases of advanced SM and SM-AHNMD when the bone marrow is directly affected.…”
Section: Clinical Manifestationsmentioning
confidence: 99%